Cognition Therapeutics Inc

01/27/2026

$CGTX conducted a Type C meeting with the to review plans for the proposed Phase 2b study of zervimesine in with Lewy bodies (DLB). : https://tinyurl.com/23vts78p

01/09/2026

It's the Friday before . Slide decks are polished. Travel plans made. Looking forward to seeing old colleagues and making new connections next week at the and Longwood Healthcare Leaders meetings.

01/07/2026

$CGTX announced that the manuscript, “Phase 2 Study of Zervimesine (CT1812) in Participants with Mild-to-Moderate Dementia with Lewy Bodies (DLB)” has been published in the journal, Alzheimer's & Dementia. The open-access article can be found here: https://tinyurl.com/26vvrqes

Cognition's chief medical officer, Dr. Caggiano, explained, "Zervimesine was shown to have a favorable impact on behavioral, cognitive, functional, and movement domains, many of which are core clinical features of DLB. There are currently no approved disease-modifying treatments for DLB, highlighting the unmet need for novel therapies.”

12/18/2025

Great advice for of people living with as we navigate this holiday season.

❄️ The holidays can be a challenging for families facing Alzheimer's or another dementia. Here are 5️⃣ tips for caregivers to ensure celebrations remain safe and joyous. Get more tips at bit.ly/3sY1DTI.

11/23/2025

In November, we recognize both and .

Family allow society’s most vulnerable members to maintain independence longer and provide physicians with critical insights. Their commitment and dedication takes a toll. That’s why this year’s theme for is .

Learn more about these important awareness months at the Alzheimer's Foundation of America : https://alzfdn.org/alzawarenessmonth/ and the Caregiver Action Network : https://www.caregiveraction.org/

,

11/19/2025

In November, we recognize both and .

More than 6 million Americans are living with Alzheimer’s disease, 80% of whom receive care in their homes. Learn more about caring for someone with dementia and available resources at the CDC: https://www.cdc.gov/caregiving/about/index.html.

You can also go at the Alzheimer's Foundation of America: https://alzfdn.org/alzawarenessmonth/. In addition to information about the 2025 awareness campaign, the has resources available to help caregivers care for themselves.

11/14/2025

Family caregivers play a vital role in our healthcare system and in our communities. But they can’t do it alone.

The theme of the 2025 NFC Month is . Learn more at https://www.caregiveraction.org/nfc2025/.

11/13/2025

Thank you to our collaborators at and our team for reaching our enrollment target in the COG0203 Phase 2 'START' study: https://tinyurl.com/22l6br3h. Impressive enrollment numbers were driven by strong interest among investigators and patients, with approximately 50% of the study population enrolled during the last six months.

The START study was designed to enroll 540 people with mild cognitive impairment ( ) or early disease who would be treated for 18 months with either the once-daily oral candidate, , or placebo. More information on the study is available at clinicaltrials.gov under study identifier NCT05531656.

11/06/2025

November is . Listen to Mary Lou Falcone's story on KSTP News: https://tinyurl.com/2842pta9. Her book, "I Didn't see it Coming" chronicles her husband's battle with Lewy body dementia (LBD) and her experiences caring for him.

11/04/2025

Last year, family caregivers provided more than 19 billion hours of care for people living with dementia from , Lewy body or other diseases. This November, let's honor by recognizing their devotion and commitment.

Read stories from dementia caregivers and learn about resources available to them at the Alzheimer's Association: https://www.alz.org/events/nadam.

10/06/2025

Hearing about the brave people who participate in clinical research is so inspiring and humbling. Thanks to the team at Banner Health for sharing this story and for continuing their legacy of healthcare excellence.

09/24/2025

What a touching story! Thank you, Banner Health for sharing it: https://tinyurl.com/2a2xmok9.

with Lewy bodies has no disease-modifying treatments. Thanks to a philanthropic donation, we were able to make (CT1812) available through an expanded access program to people who participated in the Phase 2 'SHIMMER' study as well as others with DLB who met the enrollment criteria. Banner Sun Health was the first site to open in the EAP and Dr. David Shprecher enrolled the first participants.

A promising new study at Banner Sun Health Research Institute is offering hope to people with Lewy body dementia, a condition affecting more than 1 million Americans.